Currently the only treatment we have for food allergies is avoidance.
Anti IL-13 shows promise for Asthma
For many years researchers have been looking at the Th2 pathway to decrease the asthma inflammatory response.
FDA advises against Singulair going OTC
With the push to make many allergy and asthma medications OTC, the FDA decided against Singulair becoming OTC.
Food Diversity may prevent allergic disease
A recent study showed that early exposure in early life to diverse food antigens could decrease allergy in childhood.
AAAAI Releases Second Choosing Wisely List
The AAAAI released their second choose wisely list about specific tests and procedures allergists do. Here are their 5 recommendations.
Ragweed Tablet approved
The FDA recently approved Merck’s ragweed tablet, RAGWITEK. This follows on the heels of recently approved grass tablets, GRASTEK and ORALAIR.
Miley Cyrus admitted to hospital for Allergic Reaction
Pop sensation Miley Cyrus has recently been hospitalized for an allergic reaction to antibiotics.
FDA approves Xolair for Chronic Urticaria
Today Novartis announced that Omalizumab which has been used for Allergic Asthma, has been given an indication for chronic hives.
Xolair (Omalizumab) for Chronic Urticaria
More and more studies seem to come out showing the effects of Xolair for the treatment of chronic idiopathic urticaria (CIU).
Itching is not all Histamine
Itching is predominant feature in many inflammatory and tumor related skin diseases.